drugset / Trial / NCT05849675

Pitolisant Effects on Affect and Cognition Exploratory Study (PEACE Study)

NCT05849675

Completed 58 enrolled University of Oxford
RandomizedParallel-groupTriple-blindOther

Summary

The goal of this study is to investigate the effects of selective histamine 3 antagonist pitolisant on brain function and cognition in healthy individuals. The main questions it aims to answer are: 1. Does pitolisant alter functional activity in brain regions linked to reward and cognitive processing during rest or cognitive task performance? 2. Does pitolisant alter cognitive ability across a range of psychological domains, including working memory, executive functioning and emotional processing? Participants will undertake fMRI scanning in addition to a battery of tasks designed to measure cognitive and emotional processing after taking a single dose of pitolisant or placebo. Researchers will compare differences in functional activity, cognition and emotional processing across the pitolisant and placebo groups.

Timeline

Start
2023-04-01
Primary completion
2024-02-18
Completion
2024-05-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Pitolisant Small molecule 36 mg Oral